Pasithea Therapeutics Corp.
KTTA
$0.57
-$0.03-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -83.79% | 71.62% | -232.88% | 18.27% | -4.29% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -13.27% | 12.73% | -0.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 122.05% | -130.06% | 4,182.39% | 63.91% | 130.10% |
| Change in Net Operating Assets | 114.80% | -504.04% | 22.28% | 62.35% | -220.23% |
| Cash from Operations | 1.66% | 11.30% | -86.74% | 25.30% | -26.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 200.00% |
| Issuance of Common Stock | 962.50% | -100.00% | -- | -100.00% | 253.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 66.15% | 60.35% | -- |
| Cash from Financing | 962.50% | -100.00% | 48,697.42% | -102.02% | 289.27% |
| Foreign Exchange rate Adjustments | -232.74% | 5,520.00% | -96.06% | 126.79% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.46% | -109.32% | 1,804.90% | -259.59% | 218.61% |